Reducing the Risk of Cardiovascular Disease in Patients With Diabetes
This activity presented by PTCE will focus on how newer antihyperglycemic medications can improve healthcare economics with the potential for reduction of cardiovascular disease.
Clinical Updates for Specialty Pharmacists on PCSK9 Inhibitor Therapy
This program presented by PTCE, with expert faculty, will enable participants to differentiate between the approved PCSK9 inhibitor therapies.
Specialty Pharmacy Updates on PCSK9 Inhibitor Therapy for Hypercholesterolemia
The webinar will explore the economic burden of cardiovascular complications caused by high cholesterol, criteria for a benefit from PCSK9 inhibitors, and more.
An American Journal of Managed Care Symposium: Deliberations on New and Emerging Treatments for Hyperkalemia
The panel for this activity will highlight pharmacoeconomic outcomes data and formulary decision-making strategies that can reduce the burden of hyperkalemia.